|
|
|
| Correlative analysis between the quality of life and social support in patients with recurrent ovarian cancer#br# |
Department of Gynecology Oncology, Zhejiang Cancer Hospital, Hangzhou, 310022
|
|
| Cite this article: |
|
SHAO Zhuyan,WEN Qiang,LI Dan, et al. Correlative analysis between the quality of life and social support in patients with recurrent ovarian cancer#br#[J]. JOURNAL OF WEZHOU MEDICAL UNIVERSITY, 2015, 45(9): 679-.
|
|
|
Abstract Objective: To evaluate the quality of life (QOL) and the social support in patients with recurrent ovarian cancer, and to analyze the relationship between them. Methods: 122 patients with recurrent ovarian cancer were interviewed with two questionnaires: Quality of Life Questionnaire C30 (QLQ-C30) and Perceived Social Support Scale (PSSS). Results: QOL declined in recurrent ovarian cancer, with poor global health score (56.48±22.02). Among positive ratings in five functional domains, social functioning score (64.48±25.70) was the lowest. And among reverse ratings, financial difficulties (49.45±34.61) were the most main factors reducing QOL. The social support in patients with recurrent ovarian cancer was good. The mean score of total social support was 5.64±0.94, but the mean score of family support inside (6.14±0.84) was higher than that of family support outside (5.39±1.16). The difference was statistically significant (P<0.01). It showed a negative correlation between social support and financial difficulties. Family support inside had positive correlation with score of cognitive functioning and social functioning, and negative correlation with score of fatigue and pain (P<0.05). Conclusion: Patients with recurrent ovarian cancer have poor QOL. The social support of them closely related with QOL, and we should use the social support sufficiently to improve QOL of patients.
|
|
Received: 16 February 2015
|
| |
|
|
|
[1] Beller V, Quinn MA, Benedet JL, et al. Carcinoma of the ovary. FIGO 26th annual report on the results of treatment in gynecological cancer[J]. Int J Gynaecol Obstet, 2006, 95Suppl 1: S7-S27.
[2] Rustin GJ, Vergote I, Eisenhauer E, et al. Definitions for Response and Progression in Ovarian Cancer Clinical Trials Incorporating RECIST 1.1 and CA 125 Agreed by the Gyneco-logical Cancer Intergroup (GCIG)[J]. Int J Gynecol Cancer, 2011, 21(2): 419-423.
[3] 万崇华, 陈明清, 张灿珍, 等. 癌症患者生命质量测定量表EORTC QLQ-C30中文版评介[J]. 实用肿瘤杂志, 2005, 20(4): 353-355.
[4] 汪向东, 姜长青, 马弘. 心理卫生评定量表手册(增订版)[M]. 北京: 中国心理卫生杂志社, 1999: 131-132.
[5] 丁焱, 潘颖丽. 卵巢癌病人化疗期间的社会支持调查[J].中国心理卫生杂志, 2004, 18(2): 133-134.
[6] 孙晓光, 李春颖, 吴鸣, 等. EORTC QLQ-C30中文版测定卵巢癌患者生存质量的评价[J]. 中国康复医学杂志, 2007, 22(4): 335-338.
[7] 朱敏玲, 郑修霞, 梁平, 等. 卵巢癌生存者生活质量及相关因素的调查研究[J]. 中华护理杂志, 2008, 43(1): 47-49.
[8] 郑文娴, 杨金佶, 郑张琼, 等. 家庭康复干预对全髋关节置换患者术后生活质量及功能的影响[J]. 温州医科大学学报, 2014, 44(10): 740-742. |
|
|
|
